CUE Cue Biopharma
Company Analysis
Latest News
🔴 Cue Biopharma is trading 13.6% down today amid broader market and biotech weakness
Cue Biopharma is trading 13.6% lower at $17.14 amid broad market and biotech weakness. - No fresh company-specific announcement explaining the November 5...
🔴 Cue Biopharma is trading 5.7% down with no company-specific catalyst identified
Cue Biopharma is trading at $18.54, down 5.72%, during the November 5 session; no fresh company-specific announcement explaining the decline surfaced. - The...
🔴 Cue Biopharma is trading 6.8% down in after-hours trading with no company-specific catalyst identified
Cue Biopharma is trading at $18.50, down 6.75%, with no clear company-specific explanation identified for the November 4 decline. - The latest surfaced...
🔴 Cue Biopharma is trading 10.3% down; catalyst remains unclear
Cue Biopharma is trading 10.3% lower at $18.71, with no clear company-specific catalyst identified. - Shares reversed after gaining 7.42% on November 3; no...
🔴 Cue Biopharma is trading 7.2% down — reason remains unclear
Cue Biopharma is trading 7.2% lower at $19.36 on November 4, 2026, with no clear reason identified. - No company-specific announcement or other clear catalyst...
🟢 Cue Biopharma rises 5.9% — Biotech Stocks Rally on Sector Rotation as Tech Declines
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a significant rally,...
🔴 Cue Biopharma is trading 5% down today with biotech weakness a possible factor
Cue Biopharma is trading 5.1% lower at $19.80, with biotech-sector pressure potentially contributing to the decline. - No clear company-specific announcement...
🟢 Cue Biopharma is trading 6% up with no clear catalyst identified
Cue Biopharma is trading at $22.45, up 6.10%, with no specific catalyst established. - No fresh company-specific announcement explaining the October 29 move...
🟢 Cue Biopharma is trading 11% up with no identified company-specific catalyst
Cue Biopharma is trading 11.00% up at $20.34 on October 28, 2026, with no identified company-specific announcement explaining the move. - Recent coverage...
🟢 Cue Biopharma is trading 8.08% up with no announcement explaining the move identified
Cue Biopharma is trading at $19.80, up 8.08%, with no new company-specific announcement identified to explain the October 28 move. - Recent coverage instead...
🔴 Cue Biopharma is trading 7.9% down in pre-market
Cue Biopharma is trading at $17.00, down 7.86% in pre-market, with the reason for the decline unclear. - No clear company-specific announcement or catalyst...
🔴 Cue Biopharma is trading 5.7% down in pre-market with no clear catalyst identified
Cue Biopharma is trading at $17.60, down 5.68%, in pre-market, with no clear company-specific catalyst identified. - Shares are below the $18.66 October 23...
🟢 Cue Biopharma is trading 10% up today with XBI up 2.10%
Cue Biopharma is trading 10.04% up at $18.75 on October 21, 2026, amid biotech-sector strength; no company-specific catalyst is confirmed. - The supplied...
🟢 Cue Biopharma is trading 5% up today amid biotech-sector gains
Cue Biopharma is trading 5.11% higher at $17.91 on October 21, 2026, likely reflecting broader biotechnology strength rather than a confirmed company...
🟢 Cue Biopharma is trading 11.5% up today amid a biotech-sector rally
Cue Biopharma is trading 11.5% higher at $17.93, amid a sector-led rally; biotech (XBI) was up 2.1% during the session. - No new company-specific announcement...
🟢 Cue Biopharma rises 5.1% — Biotech Sector Surges on M&A Activity and Positive Clinical Trial Data
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector is experiencing a significant...
🔴 Cue Biopharma is trading 6.7% down in pre-market; no confirmed company-specific catalyst
Cue Biopharma is trading at $15.01, down 6.65%, with no confirmed company-specific catalyst identified for the October 20 pre-market decline. - The biotech...
🟢 Cue Biopharma is trading 8.44% up in pre-market
Cue Biopharma is trading 8.44% up at $17.44 in pre-market on October 20, 2026; no new company announcement explaining the move was identified. - Positive...
🟢 Cue Biopharma is trading 7.72% up in pre-market
CUE is trading at $18.00, up 7.72% in pre-market.
🔴 Cue Biopharma falls 5.8% — Biotech Sector Declines Amid Broad Market Rotation
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as represented by the XBI...